H. Neu

发表

The release of enzymes from Escherichia coli by osmotic shock and during the formation of spheroplasts.

H. Neu, L. Heppel, 1965, The Journal of biological chemistry.

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria

H. Neu, N. Chin, 1984, Antimicrobial Agents and Chemotherapy.

In Vitro Studies of Tobramycin, an Aminoglycoside Antibiotic

H. Neu, J. Dienstag, Harold C. Neu, 1972, Antimicrobial Agents and Chemotherapy.

Antibiotic resistance. Epidemiology and therapeutics.

R N Jones, W Schaffner, W. Schaffner, 1992, Diagnostic microbiology and infectious disease.

The Crisis in Antibiotic Resistance

H. Neu, Harold C. Neu, 1992, Science.

Purification and characterization of penicillinases from Salmonella typhimurium and Escherichia coli.

H. Neu, E. Winshell, 1970, Archives of biochemistry and biophysics.

The surface localization of penicillinases in Escherichia coli and Salmonella typhimurium.

H. Neu, 1968, Biochemical and biophysical research communications.

Major advances in antibacterial quinolone therapy.

H. Neu, 1994, Advances in pharmacology.

Plasma Bactericidal Activity of a New C‐5 Methyl Fluoroquinolone After Oral Doses of 400 and 800 mg

H. Neu, J. Gu, W. Fang, 1992, Journal of clinical pharmacology.

Pharmacokinetics, microbiology, cost: interrelated problems for the 1990s that impact on the use of fluoroquinolone antimicrobial agents.

H. Neu, 1992, The American journal of medicine.

Resistance of Pseudomonas aeruginosa to Imipenem

H. Neu, 1992, Infection Control & Hospital Epidemiology.

ORAL CIPROFLOXACIN THERAPY OF INFECTIONS DUE TO PSEUDOMONAS AERUGINOSA

H. Neu, B. Scully, M. Parry, 1986, The Lancet.

Relation of structural properties of beta-lactam antibiotics to antibacterial activity.

H. Neu, 1985, The American journal of medicine.

Mupirocin treatment of nasal staphylococcal colonization.

H. Neu, J. Gu, B. Scully, 1992, Archives of internal medicine.

Antibacterial activity of coumermycin alone and in combination with other antibiotics

H. Neu, N. Chin, P. Labthavikul, 1984, Antimicrobial Agents and Chemotherapy.

Bacampicillin Hydrochloride: Chemistry, Pharmacology, and Clinical Use

H. Neu, R. Scheife, 1982, Pharmacotherapy.

The comparative synergistic activity of amikacin, gentamicin, netilmicin and azlocillin, mezlocillin, carbenicillin and ticarcillin against Serratia marcescens.

H. Neu, K. Fu, 1978, The Journal of antibiotics.

INFECTIVE ENDOCARDITIS—AN EVOLVING DISEASE: A Review of Endocarditis at The Columbia‐Presbyterian Medical Center, 1968–1973

H. Neu, G. Garvey, 1978, Medicine.

The inhibitory quotient. A method for interpreting minimum inhibitory concentration data.

H. Neu, P. Ellner, 1981, JAMA.

The inhibitory quotient.

H. Neu, P. Ellner, 1983, Bulletin of the New York Academy of Medicine.

Testing the physician's knowledge of antibiotic use: Self-assessment and learning via videotape.

H. Neu, H C Neu, S P Howrey, 1975, The New England journal of medicine.

What should the clinician expect from the microbiology laboratory?

H. Neu, 1978, Annals of internal medicine.

How is the medical student being trained in microbiology and infections?

H. Neu, 1978, Annals of internal medicine.

The Nephrotoxicity of Antimicrobial Agents

H. Neu, G. Appel, 1977 .

NEPHROTOXICITY OF ANTIMICROBIAL AGENTS — SECOND OF THREE PARTS

H. Neu, G. Appel, 1977, The New England journal of medicine.

New macrolide antibiotics: azithromycin and clarithromycin.

H. Neu, 1992, Annals of internal medicine.

Clinical microbiology of azithromycin.

H. Neu, H. C. Neu, 1991, The American journal of medicine.

A Symposium on the Tetracyclines: A Major Appraisal: The New York Academy of Medicine: Symposium Summary

H. Neu, 1978 .

Oral ciprofloxacin therapy of infection caused by multiply resistant bacteria other than Pseudomonas aeruginosa.

H. Neu, B. Scully, 1986, The Journal of antimicrobial chemotherapy.

The Aminoglycosides: Microbiology, Clinical Use, and Toxicology

H. Neu, A. Whelton, 1982 .

Cefamandole, a Cephalosporin Antibiotic with an Unusually Wide Spectrum of Activity

H. Neu, Harold C. Neu, 1974, Antimicrobial Agents and Chemotherapy.

Safety of cefepime: a new extended-spectrum parenteral cephalosporin.

H. Neu, H. C. Neu, 1996, The American journal of medicine.

Streptococcus agalactiae (group B) endocarditis — A description of twelve cases and review of the literature

H. Neu, D. Spriggs, B. Scully, 1987, Infection.

Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporin

H. Neu, N. Chin, P. Labthavikul, 1984, Antimicrobial Agents and Chemotherapy.

Cefoxitin, a Semisynthetic Cephamycin Antibiotic: Antibacterial Spectrum and Resistance to Hydrolysis by Gram-Negative Beta-Lactamases

H. Neu, 1974, Antimicrobial Agents and Chemotherapy.

Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks

H. Neu, J. Washington, J. Anhalt, 1985, Journal of clinical microbiology.

Antimicrobial agents: bacterial/fungal

H. Neu, R. Finch, 1989 .

Antimicrobial agents: Mechanisms of action and clinical usage

H. Neu, 1973 .

Probenecid-resistant J774 cell expression of enhanced organic anion transport by a mechanism distinct from multidrug resistance.

D. Cohen, H. Neu, T. Steinberg, 1993, Infectious agents and disease.

Current mechanisms of resistance to antimicrobial agents in microorganisms causing infection in the patient at risk for infection.

H. Neu, 1984, The American journal of medicine.

Cefuroxime, a Beta-Lactamase-Resistant Cephalosporin with a Broad Spectrum of Gram-Positive and -Negative Activity

H. Neu, K. Fu, 1978, Antimicrobial Agents and Chemotherapy.

The in-vitro activity and β-lactamase stability of carumonam

H. Neu, N. Chin, Pornpen Labthavikul, 1986 .

Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation.

A. Prince, L. Saiman, H. Neu, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Penicillin-binding proteins and role of amdinocillin in causing bacterial cell death.

H. Neu, 1983, The American journal of medicine.

Synergy of Mecillinam, a Beta-Amidinopenicillanic Acid Derivative, Combined with Beta-Lactam Antibiotics

H. Neu, 1976, Antimicrobial Agents and Chemotherapy.

Mecillinam, a Novel Penicillanic Acid Derivative with Unusual Activity Against Gram-Negative Bacteria

H. Neu, 1976, Antimicrobial Agents and Chemotherapy.

THE PHARMACOLOGY OF NEWER AMINOGLYCOSIDES, WITH A CONSIDERATION OF THE APPLICATION TO CLINICAL SITUATIONS

H. Neu, 1977, The Medical journal of Australia.

In Vitro Study of Netilmicin Compared with Other Aminoglycosides

H. Neu, K. Fu, 1976, Antimicrobial Agents and Chemotherapy.

In vitro activity of the new fluoroquinolone CP-99,219

H. Neu, N. Chin, H. C. Neu, 1994, Antimicrobial Agents and Chemotherapy.

Antimicrobial Chemotherapy, 1934–1994

H. Neu, 1994 .

Amoxycillin/clavulanic acid: a review of its efficacy in over 38,500 patients from 1979 to 1992.

H. Neu, A. Wilson, R. Grüneberg, 1993, Journal of chemotherapy.

Imipenem: a new carbapenem antibiotic.

H. Neu, B. Lipman, B. Lipman, 1988, The Medical clinics of North America.

Carbapenems: special properties contributing to their activity.

H. Neu, 1985, The American journal of medicine.

Structure-Activity Relations of New β-Lactam Compounds and in Vitro Activity Against Common Bacteria

H. Neu, 1983 .

Systemic infections treated with amdinocillin in combination with other beta-lactam antibiotics.

H. Neu, T. Beam, J. King, 1983, The American journal of medicine.

Mechanisms of bacterial resistance to antimicrobial agents, with particular reference to cefotaxime and other beta-lactam compounds.

H. Neu, 1982, Reviews of infectious diseases.

Carbenicillin and ticarcillin.

H. Neu, 1982, The Medical clinics of North America.

Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria

H. Neu, N. Chin, P. Labthavikul, 1987, Antimicrobial Agents and Chemotherapy.

Azlocillin and Mezlocillin: New Ureido Penicillins

H. Neu, K. Fu, Harold C. Neu, 1978, Antimicrobial Agents and Chemotherapy.

Ceftibuten: minimal inhibitory concentrations, postantibiotic effect and beta‐lactamase stability—a rationale for dosing programs

H. Neu, 1995, The Pediatric infectious disease journal.

Postantibiotic effect of ceftibuten on respiratory pathogens

H. Neu, N. Chin, H. B. Huang, 1995, The Pediatric infectious disease journal.

A perspective on therapy of Lyme infection.

H. Neu, H. C. Neu, 1988, Annals of the New York Academy of Sciences.

Ceftizoxime: A Beta‐Lactamase‐Stable, Broad‐Spectrum Cephalosporin

H. Neu, 1984, Pharmacotherapy.

Activity of mersacidin, a novel peptide, compared with that of vancomycin, teicoplanin, and daptomycin

H. Neu, W. Niu, 1991, Antimicrobial Agents and Chemotherapy.

In vitro activity of OPC-17116

H. Neu, J. Gu, N. Chin, 1992, Antimicrobial Agents and Chemotherapy.

Piperacillin, a new penicillin active against many bacteria resistant to other penicillins

H. Neu, K. Fu, 1978, Antimicrobial Agents and Chemotherapy.

THE BIOCHEMICAL BASIS OF ANTIMICROBIAL AND BACTERIAL RESISTANCE*

H. Neu, 2006 .

Comparative Activity and β-Lactamase Stability of Cefoperazone, a Piperazine Cephalosporin

H. Neu, N. Aswapokee, K. Fu, 1979, Antimicrobial Agents and Chemotherapy.

Trimethoprim alone for treatment of urinary tract infection.

H. Neu, 1982, Reviews of infectious diseases.

Antimicrobial resistance and R-factor transfer among isolates of Salmonella in the northeastern United States: a comparison of human and animal isolates.

H. Neu, C. Cherubin, J. Winter, 1975, The Journal of infectious diseases.

Reduction in Tuberculin Skin-Test Conversions Among Medical House Staff Associated with Improved Tuberculosis Infection Control Practices

H. Neu, D. Bangsberg, A. Moss, 1997, Infection Control & Hospital Epidemiology.

The use of mupirocin in controlling methicillin-resistant Staphylococcus aureus.

H. Neu, 1990, Infection control and hospital epidemiology.

Carbenicillin: clinical and laboratory experience with a parenterally administered penicillin for treatment of Pseudomonas infections.

H. Neu, H. Swarz, 1969, Annals of internal medicine.

Elimination of Staphylococcus aureus Nasal Carriage in Health Care Workers: Analysis of Six Clinical Trials with Calcium Mupirocin Ointment

B. Doebbeling, R. Wenzel, J. Mcgowan, 1993 .

In vitro activity of sparfloxacin

H. Neu, J. Gu, N. Chin, 1991, Antimicrobial Agents and Chemotherapy.

Changing Mechanisms of Bacterial Resistance

H. Neu, 1984 .

Treatment of lower respiratory tract infections due to Pseudomonas aeruginosa in patients with cystic fibrosis.

A. Prince, H. Neu, B. Scully, 1985, Reviews of infectious diseases.

The new beta-lactamase-stable cephalosporins.

H. Neu, 1982, Annals of internal medicine.

National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species.

M. A. Martin, L. Saiman, R. Wenzel, 1998, Diagnostic microbiology and infectious disease.

The use of drugs in renal failure.

H. Neu, G. Appel, 1979, Disease-a-month : DM.

The pharmacokinetic and bactericidal characteristics of oral cefixime

H. Neu, B. Scully, T. Hirose, 1985, Clinical pharmacology and therapeutics.

Incidence of diarrhea and colitis associated with clindamycin therapy.

A. Prince, H. Neu, G. Garvey, 1977, The Journal of infectious diseases.

Bone and joint infections due to Salmonella.

J. Marr, H. Neu, C. Cherubin, 1978, The Journal of infectious diseases.

Antimicrobial activity, bacterial resistance, and antimicrobial pharmacology. Is it possible to use new agents cost-effectively?

H. Neu, 1985, The American journal of medicine.

Unusual nosocomial infections

H. Neu, 1984, Disease-a-Month.

In vitro activity of teichomycin compared with those of other antibiotics

H. Neu, P. Labthavikul, 1983, Antimicrobial Agents and Chemotherapy.

INFECTIONS IN INTE NSIVE CARE PATIENTS: USE OF NEW B-LACTAMS*

H. Neu, 2006 .

Clinical Therapeutic Conference

H. Neu, 1992 .

Correlation of Netilmicin Disk Diffusion Susceptibility and Agar Dilution Susceptibility

H. Neu, K. Fu, 1979, Antimicrobial Agents and Chemotherapy.

Clinical evaluation of netilmicin therapy in serious infections.

H. Neu, K. Fu, J. Jahre, 1979, The American journal of medicine.

Tobramycin: an overview.

H. Neu, H. C. Neu, 1976, The Journal of infectious diseases.

NUCLEOTIDE SEQUENCE ANALYSIS OF POLYRIBONUCLEOTIDES BY MEANS OF PERIODATE OXIDATION FOLLOWED BY CLEAVAGE WITH AN AMINE.

H. Neu, L. Heppel, 1964, The Journal of biological chemistry.

Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporin

H. Neu, N. Chin, G. Saha, 1989, Antimicrobial Agents and Chemotherapy.

Amdinocillin: A Novel Penicillin; Antibacterial Activity, Pharmacology and Clinical Use

H. Neu, 1985, Pharmacotherapy.

Infective endocarditis at the Presbyterian Hospital in New York City from 1938-1967.

H. Neu, C. Cherubin, 1971, The American journal of medicine.

Optimal antibiotic therapy in bronchopulmonary infections

H. Neu, 2005, Infection.

Ampicillin Resistance and Beta-Lactamase Activity in Clinical Isolates of Shigella Sonnei

A. Prince, H. Neu, 1976 .

THE RELEASE OF RIBONUCLEASE INTO THE MEDIUM WHEN ESCHERICHIA COLI CELLS ARE CONVERTED TO SPEROPLASTS.

H. Neu, L. Heppel, 1964, The Journal of biological chemistry.

Infections and Antibiotic Usage in Patients with Renal Diseases

H. Neu, G. Appel, 1983 .

Synergy of fosfomycin with beta-lactam antibiotics against staphylococci and aerobic gram-negative bacilli.

H. Neu, N. Chin, N. Neu, 1986, Drugs under experimental and clinical research.

Chronic granulomatous disease of childhood with renal involvement.

H. Neu, R. Ehrlich, W. Blanc, 1974, Urology.

Urinary tract infections.

H. Neu, 1992, The American journal of medicine.

Pharmacokinetics of ticarcillin in patients with abnormal renal function.

H. Neu, M. F. Parry, 1976, The Journal of infectious diseases.

Synergy of new C-3 substituted cephalosporins and tobramycin against Pseudomonas aeruginosa and Pseudomonas cepacia.

H. Neu, N. Chin, 1989, Diagnostic microbiology and infectious disease.

The AIDS Knowledge Base: A Textbook on HIV Disease From the University of California, San Francisco, and the San Francisco General Hospital

H. Neu, 1990 .

Histoplasmosis in patients with the acquired immune deficiency syndrome.

H. Neu, W. Mandell, D. Goldberg, 1986, The American journal of medicine.

Resistance to ciprofloxacin appearing during therapy.

H. Neu, N. Chin, N. Clynes, 1989, The American journal of medicine.

Ciprofloxacin therapy in cystic fibrosis.

H. Neu, B. Scully, C. Ores, 1987, The American journal of medicine.

Aspergillus endocarditis in children: case report and review of the literature.

A. Prince, H. Neu, R. Barst, 1981, Pediatrics.

Acute interstitial nephritis associated with carbenicillin therapy.

B. Woda, H. Neu, G. Appel, 1978, Archives of internal medicine.

Late hematogenous infection of total joint replacement.

H. Neu, L. Bigliani, F. Stinchfield, 1980, The Journal of bone and joint surgery. American volume.

Cephalosporin antibiotics as applied in surgery of bones and joints.

H. Neu, 1984, Clinical orthopaedics and related research.

Infections due to gram-negative bacteria: an overview.

H. Neu, 1985, Reviews of infectious diseases.

Trends in the development of beta-lactam antibiotics.

H. Neu, 1984, Scandinavian journal of infectious diseases. Supplementum.

Cephalosporins in the Treatment of Meningitis

H. Neu, 2012, Drugs.

The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.

H. Neu, J. Gu, N. Chin, 1992, Journal of Antimicrobial Chemotherapy.

β-Lactam Antibiotics: Structural Relationships Affecting in Vitro Activity and Pharmacologic Properties

H. Neu, H. C. Neu, 1986 .

Cefatrizine Activity Compared with That of Other Cephalosporins

H. Neu, K. Fu, 1979, Antimicrobial Agents and Chemotherapy.

In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime.

H. Neu, 1987, The Pediatric infectious disease journal.

Structure-activity relationships: biological

H. Neu, 1992 .

In vitro activity and beta-lactamase stability of LJC 10,627

H. Neu, J. Gu, N. Chin, 1992, Antimicrobial Agents and Chemotherapy.

The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.

H. Neu, 1982, Annual review of pharmacology and toxicology.

Antibacterial activity of an oral penem, Sch 29482.

H. Neu, P. Labthavikul, 1982, The Journal of antimicrobial chemotherapy.

The in-vitro activity of a novel penem FCE 22101 compared to other beta-lactam antibiotics.

H. Neu, N. Chin, P. Labthavikul, 1985, The Journal of antimicrobial chemotherapy.

Cefaclor: In Vitro Spectrum of Activity and Beta-Lactamase Stability

H. Neu, K. Fu, 1978, Antimicrobial Agents and Chemotherapy.

In vitro activity and beta-lactamase stability of a new penem, CGP 31608

H. Neu, N. Chin, N. Neu, 1987, Antimicrobial Agents and Chemotherapy.

Expanding indications for the new macrolides, azalides, and streptogramins.

H. Neu, L. Young, É. Chaslus-Dancla, 1997 .

In vitro activity of LY264826 compared to other glycopeptides and daptomycin.

H. Neu, N. Chin, 1991, Diagnostic microbiology and infectious disease.

Quinolone antimicrobial agents.

H. Neu, Harold C. Neu, 1992, Annual review of medicine.

Synergy of fluoroquinolones with other antimicrobial agents.

H. Neu, 1989, Reviews of infectious diseases.

Quinolones : the present and the future

H. Neu, S. Gorbach, 1994 .

HR 756, a New Cephalosporin Active Against Gram-Positive and Gram-Negative Aerobic and Anaerobic Bacteria

H. Neu, N. Aswapokee, K. Fu, 1979, Antimicrobial Agents and Chemotherapy.

Clavulanic Acid, a Novel Inhibitor of β-Lactamases

H. Neu, K. Fu, 1978, Antimicrobial Agents and Chemotherapy.

In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim

H. Neu, N. Chin, 1983, Antimicrobial Agents and Chemotherapy.

Quinolones in perspective.

H. Neu, 1990, Journal of Antimicrobial Chemotherapy.

On the surface localization of enzymes in E. coli.

H. Neu, L. Heppel, 1964, Biochemical and biophysical research communications.

Effect of trimethoprim and trimethoprim-sulfamethoxazole on development of drug-resistant vaginal and fecal floras

H. Neu, D. Hyams, S. Pancoast, 1980, Antimicrobial Agents and Chemotherapy.

Parasitic infections: therapeutic considerations.

H. Neu, W. Mandell, 1988, The Medical clinics of North America.

Synergy and Antagonism of Fluoroquinolones with Other Classes of Antimicrobial Agents

H. Neu, 2012, Drugs.

Synergy and antagonism of combinations with quinolones

H. Neu, 1991, European Journal of Clinical Microbiology and Infectious Diseases.

Combination of ofloxacin and other antimicrobial agents.

H. Neu, N. Chin, 1990, Journal of chemotherapy.

Synergy of imipenem--a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter species.

H. Neu, N. Chin, 1987, Chemotherapy.

Factors influencing the in vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620

H. Neu, L. Hirschhorn, 1986, Antimicrobial Agents and Chemotherapy.

Macrolides: Problems and Promises

H. Neu, 1988, Journal of clinical pharmacology.

Gastrointestinal histoplasmosis

H. Neu, M. Cappell, M. Grimes, 2005, Digestive Diseases and Sciences.

Primary cutaneous aspergillosis in six leukemic children.

H. Neu, M. Grossman, M. Fracaro, 1985, Journal of the American Academy of Dermatology.

Factors that affect the in-vitro activity of cephalosporin antibiotics.

H. Neu, 1982, The Journal of antimicrobial chemotherapy.

Experience with amoxicillin: an overall summary of clinical trials in the United States.

H. Neu, P. Wise, 1974, The Journal of infectious diseases.

In Vitro Activity and β-Lactamase Stability of Cefazaflur Compared with Those of β-Lactamase-Stable Cephalosporins

H. Neu, N. Aswapokee, 1979, Antimicrobial Agents and Chemotherapy.

In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone

H. Neu, N. Chin, D. Brittain, 1986, Antimicrobial Agents and Chemotherapy.

Antibiotic Ciprofloxacin Amoxicillin Ciprofloxacin Norfloxacin Cephalexin Amoxicillin Ciprofloxacin Ciprofloxacin Amoxicillin Ciprofloxacin Norfloxacin Ceftazidime Cephalexin Amoxicillin Trimethoprim Ciprofloxacin Norfloxacin Cephalexin Amoxicillin Trimethoprim Ciprofloxacin Norfloxacin Cefotaxime

H. Neu, N. Chin, 2003 .

Bacterial resistance to fluoroquinolones.

H. Neu, 1988, Reviews of infectious diseases.

In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agents

H. Neu, W. Mandell, 1986, Antimicrobial Agents and Chemotherapy.

In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim

H. Neu, P. Labthavikul, 1982, Antimicrobial Agents and Chemotherapy.

Clinical utility of DNA gyrase inhibitors.

H. Neu, 1989, Pharmacology & therapeutics.

Quinolones: a new class of antimicrobial agents with wide potential uses.

H. Neu, 1988, The Medical clinics of North America.

7 – The Quinolones: Prospects

H. Neu, 1988 .

Use of Fluoroquinolone Antimicrobial Agents by Cardiovascular and Cardiopulmonary Surgeons

H. Neu, 2022 .

Beta-Lactamase Stability of HR 756, a Novel Cephalosporin, Compared to That of Cefuroxime and Cefoxitin

H. Neu, K. Fu, 1978, Antimicrobial Agents and Chemotherapy.

Semisynthetic penicillin 6-(D(--)-alpha-carboxy-3-thienylacetamido) penicillanic acid active against Pseudomonas in vitro.

H. Neu, E. Winshell, 1971, Applied microbiology.

The release of ribonuclease into the medium when E. coli cells are converted to spheroplasts.

H. Neu, L. Heppel, 1964, Biochemical and biophysical research communications.

Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability

H. Neu, P. Labthavikul, 1982, Antimicrobial Agents and Chemotherapy.

Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors.

H. Neu, K. Fu, 1981, The Journal of antimicrobial chemotherapy.

Antibacteroides and β-lactamase inhibitory activities of moxalactam

H. Neu, K. Fu, 1981 .

Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin

H. Neu, K. Fu, 1980, Antimicrobial Agents and Chemotherapy.

Ticarcillin for treatment of serious infections with gram-negative bacteria.

H. Neu, M. F. Parry, M. Parry, 1976, The Journal of infectious diseases.

Kinetics of mezlocillin and carbenicillin

H. Neu, S. Pancoast, 1978, Clinical pharmacology and therapeutics.

Antibacterial Activity of a New 1-Oxa Cephalosporin Compared with That of Other β-Lactam Compounds

H. Neu, N. Aswapokee, K. Fu, 1979, Antimicrobial Agents and Chemotherapy.

Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.

H. Neu, N. Chin, 1987, The American journal of medicine.

In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria

H. Neu, T. Barlam, 1984, Antimicrobial Agents and Chemotherapy.

Agar disk diffusion susceptibility characteristics of azlocillin, carbenicillin, mezlocillin, piperacillin, and ticarcillin

H. Neu, D. Phaneuf, 1979, Antimicrobial Agents and Chemotherapy.

In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746

H. Neu, N. Chin, 1988, Antimicrobial Agents and Chemotherapy.

The activity of BMY 28142 a new broad spectrum β-lactamase stable cephalosporin

H. Neu, N. Chin, P. Labthavikul, 1986 .

Achromobacter xylosoxidans bacteremia.

H. Neu, W. Mandell, G. Garvey, 1987, Reviews of infectious diseases.

Clinical evaluation of piperacillin therapy for infection.

A. Prince, H. Neu, S. Pancoast, 1981, Archives of internal medicine.

Effect of human lysozyme on gram-positive and gram-negative bacteria.

R. Canfield, H. Neu, J. Dreyfus, 1968, Antimicrobial agents and chemotherapy.

Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam.

H. Neu, P. Labthavikul, 1982, The Journal of antimicrobial chemotherapy.

The role of inducible beta-lactamases in the antagonism seen with certain cephalosporin combinations.

H. Neu, K. Fu, 1981, The Journal of antimicrobial chemotherapy.

Synergy of Azlocillin and Mezlocillin Combined With Aminoglycoside Antibiotics and Cephalosporins

H. Neu, K. Fu, Harold C. Neu, 1978, Antimicrobial Agents and Chemotherapy.

Comparative In Vitro Activity and Clinical Pharmacology of Ticarcillin and Carbenicillin

H. Neu, G. Garvey, 1975, Antimicrobial Agents and Chemotherapy.

In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338

H. Neu, N. Chin, A. Novelli, 1989, Antimicrobial Agents and Chemotherapy.

The prospects of treatment failure in the chemotherapy of infectious diseases in the 1990s.

A. Tomasz, H. Neu, D. Armstrong, 1995, Microbial drug resistance.

Antibacterial activity and beta-lactamase stability of ceftazidime, an aminothiazolyl cephalosporin potentially active against Pseudomonas aeruginosa

H. Neu, P. Labthavikul, 1982, Antimicrobial Agents and Chemotherapy.

In Vitro Antibacterial Activity and β-Lactamase Stability of SCE-129, a New Cephalosporin

H. Neu, K. Fu, 1979, Antimicrobial Agents and Chemotherapy.

Glycopeptides and lipopeptides Agents trying to meet the demands of the future

H. Neu, 1988 .

In vitro activity and beta-lactamase stability of two oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074)

H. Neu, N. Chin, P. Labthavikul, 1986, Antimicrobial Agents and Chemotherapy.

The emergence of bacterial resistance and its influence on empiric therapy.

H. Neu, 1983, Reviews of infectious diseases.

A Review and Summary of the Pharmacokinetics of Cefoperazone: A New, Extended‐Spectrum β‐Lactam Antibiotic

H. Neu, 1981, Therapeutic drug monitoring.

Antimicrobial activity and human pharmacology of amoxicillin.

H. Neu, 1974, The Journal of infectious diseases.

InVitro Activity andP-Lactamase Stability ofaMonobactam, SQ26,917, Compared withThoseofAztreonam andOther Agents

H. Neu, 1983 .

Antibacterial activity of desacetylcefotaxime alone and in combination with cefotaxime.

H. Neu, 1982, Reviews of infectious diseases.

HR 756, aNewCephalosporin Active Against Gram-Positive andGram-Negative Aerobic andAnaerobic Bacteria

H. Neu, Andkwung P. Fu, 1979 .

New penicillins and their use in pediatrics.

A. Prince, H. Neu, 1983, Pediatric clinics of North America.

Use of cefotaxime, a beta-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms.

H. Neu, E. Francke, 1981, The American journal of medicine.

Pathophysiologic basis for the use of third-generation cephalosporins.

H. Neu, 1990, The American journal of medicine.

Clinical perspectives on imipenem.

H. Neu, 1983, The Journal of antimicrobial chemotherapy.

Comparative InVitro Activity andP-Lactamase Stability ofFK482, aNewOralCephalosporin

H. Neu, 1989 .

Diffusion Disk Susceptibility Testing with Cefotaxime

H. Neu, N. Aswapokee, K. Fu, 1979, Antimicrobial Agents and Chemotherapy.

Antibacterial Activity of Ceftriaxone (Ro 13-9904), a β-Lactamase-Stable Cephalosporin

H. Neu, N. Meropol, FU KWUNGP., 1981, Antimicrobial Agents and Chemotherapy.

In-vitro activity of ceftazidime, a β -lactamase stable cephalosporin

H. Neu, 1981 .

The efficacy of ceftizoxime in treating infections due to organisms resistant to other antibiotics.

H. Neu, 1982, The Journal of antimicrobial chemotherapy.

Combination of ceftizoxime with azlocillin, mezlocillin, piperacillin and ticarcillin.

H. Neu, 1982, The Journal of antimicrobial chemotherapy.

Pharmacology of ceftizoxime compared with that of cefamandole

H. Neu, S. Srinivasan, 1981, Antimicrobial Agents and Chemotherapy.

Aztreonam: A novel monocyclic beta-lactam antibiotic

H. Neu, 1985 .

Pharmacokinetics, Adverse Effects and Clinical Use

H. Neu, 2012 .

In vitro activity and beta-lactamase stability of cefodizime, an aminothiazolyl iminomethoxy cephalosporin

H. Neu, B. Scully, K. Jules, 1983, Antimicrobial Agents and Chemotherapy.

Antibacterial Activity and ,-Lactamase Stability of Ceftazidime , an Aminothiazolyl Cephalosporin Potentially Active Against Pseudomonas aeruginosa

H. Neu, Pornpen Labthavikul, 2022 .

What do β-lactamases mean for clinical efficacy?

H. Neu, 2005, Infection.

Hemorrhagic bullae associated with salmonella septicemia.

Steven Wolinsky, H. Neu, D. Silvers, 1981, New York state journal of medicine.

Contemporary antibiotic therapy in otolaryngology.

H. Neu, 1984, Otolaryngologic clinics of North America.

Comparative Inhibition of β-Lactamases by Novel β-Lactam Compounds

H. Neu, K. Fu, Harold C. Neu, 1979, Antimicrobial Agents and Chemotherapy.

Azlocillin andMezlocillin: NewUreido Penicillins

H. Neu, K. Fu, 1978 .

A sulfone beta-lactam compound which acts as a beta-lactamase inhibitor.

H. Neu, N. Aswapokee, 1978, The Journal of antibiotics.

The neurological aspects of Nocardia asteroides infection.

H. Neu, R. Richter, P. Silverstein, 1968, Research publications - Association for Research in Nervous and Mental Disease.

Infectious diseases and antimicrobial agents

H. Neu, J. Williams, A. Whelton, 1981 .

Necrotizing nocardial pneumonitis.

H. Neu, M. Silva, E. Hazen, 1967, Annals of internal medicine.

Toxoplasmosis, lymphoma, or both?

H. Neu, J. Ultmann, M. Ochoa, 1969, Annals of internal medicine.

The nephrotoxicity of antimicrobial agents Pt 3.

H. Neu, G. Appel, 1977 .

Candida parapsilosis endocarditis: medical and surgical cure.

H. Neu, S. Pancoast, E. Martín, 1979, Annals of internal medicine.

Aztreonam activity, pharmacology, and clinical uses.

H. Neu, H. C. Neu, 1990, The American journal of medicine.

Aztreonam: the first monobactam.

H. Neu, 1988, The Medical clinics of North America.

Pharmacology of aztreonam after intravenous infusion

H. Neu, E. Swabb, B. Scully, 1983, Antimicrobial Agents and Chemotherapy.

Antibacterial activity of a monocyclic β-lactam SQ 26,776

H. Neu, Pornpen Labthavikul, 1981 .

Stevens-Johnson syndrome due to Mycoplasma pneumoniae in an adult.

H. Neu, M. Grossman, R. Kalb, 1985, The American journal of medicine.

Use of antimicrobial agents to treat central nervous system infection.

H. Neu, O. Klein, 1992, Neurosurgery clinics of North America.

Pharmacokinetics of cefotaxime

H. Neu, I. Ho, K. Fu, 1979, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics ofIntravenous Piperacillin inPatients Undergoing Chronic Hemodialysis

H. Neu, G. Appel, 1979 .

Pharmacokinetics of ceftriaxone after intravenous infusion and intramuscular injection.

H. Neu, B. Scully, K. Fu, 1984, The American journal of medicine.

Agents responsible for infection in chronic granulomatous disease of childhood.

H. Neu, G. M. Lazarus, 1975, The Journal of pediatrics.

Cefotaxime kinetics after intravenous and intramuscular injection of single and multiple doses

H. Neu, I. Ho, K. Fu, 1980, Clinical pharmacology and therapeutics.

Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds.

H. Neu, 1978, The Journal of infectious diseases.

Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.

H. Neu, B. Scully, 1985, The American journal of medicine.

Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection

H. Neu, N. Chin, K. Jules, 1986, European Journal of Clinical Microbiology.

In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporin

H. Neu, N. Chin, H. Huang, 1993, Antimicrobial Agents and Chemotherapy.

The role of β-lactamase inhibitors in chemotherapy

H. Neu, 1985 .

In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones

H. Neu, N. Chin, A. Novelli, 1988, Antimicrobial Agents and Chemotherapy.

In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents.

H. Neu, N. Chin, P. Labthavikul, 1984, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin

H. Neu, N. Meropol, K. Fu, 1981, Antimicrobial Agents and Chemotherapy.

Ototoxicity of tobramycin: a clinical overview.

H. Neu, C. L. Bendush, 1976, The Journal of infectious diseases.

In vitro activity of SCE-2787, a new cephalosporin with potent activity against Pseudomonas aeruginosa and members of the family Enterobacteriaceae

H. Neu, N. Chin, O. Klein, 1994, Antimicrobial Agents and Chemotherapy.

Pharmacology of ticarcillin combined with clavulanic acid in humans.

H. Neu, N. Chin, B. Scully, 1985, The American journal of medicine.

Microbiologic aspects of fluoroquinolones.

H. Neu, 1991, American journal of ophthalmology.

Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro

H. Neu, M. F. Parry, 1977, Journal of clinical microbiology.

In vitro activity of fleroxacin in combination with other antimicrobial agents.

H. Neu, N. Chin, 1993, The American journal of medicine.

Fleroxacin combined with rifampin.

H. Neu, Y. Zhang, 1991, Diagnostic microbiology and infectious disease.

Aminoglycosides: Do We Need New Agents?

H. Neu, 2012, Drugs.

1-N HAPA gentamicin B, a new aminoglycoside active against gentamicin resistant isolates--activity compared to other aminoglycosides.

H. Neu, K. Fu, 1978, The Journal of antibiotics.

In-vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents.

H. Neu, T. Kumada, 1985, The Journal of antimicrobial chemotherapy.

New Broad-Spectrum Penicillins

H. Neu, 2012, Drugs.

Emergence of resistance to chloramphenicol in salmonella.

H. Neu, L. Sabath, J. Rahal, 1977, The Journal of infectious diseases.

Antimicrobial Resistance and R-Factors in Salmonella Isolated from Humans and Animals

H. Neu, C. Cherubin, E. Longo, 1975 .

Antibiotic resistance of Salmonella in the eastern United States.

H. Neu, C. Cherubin, E. Winshell, 1969, Antimicrobial agents and chemotherapy.

Antibiotic resistance of fecal Escherichia coli. A comparison of samples from children of low and high socioeconomic groups.

H. Neu, C. Cherubin, M. Vogt, 1973, American journal of diseases of children.

Interbacterial Transfer of R Factor in Humans

H. Neu, E. Winshell, P. Huber, 1973, Antimicrobial Agents and Chemotherapy.

Antimicrobial Resistance of Shigella Isolated in New York City in 1973

H. Neu, C. Cherubin, J. Winter, 1975, Antimicrobial Agents and Chemotherapy.

Antibiotic resistance of salmonella in northeastern United States 1968-199.

H. Neu, C. Cherubin, E. Winshell, 1971, New York state journal of medicine.

β-Lactamases, β-lactamase inhibitors, and skin and skin-structure infections

H. Neu, 1990 .

In vitro activity of S-ofloxacin

H. Neu, N. Chin, 1989, Antimicrobial Agents and Chemotherapy.

SOME OBSERVATIONS ON THE "LATENT" RIBONUCLEASE OF ESCHERICHIA COLI.

H. Neu, L. Heppel, 1964, Proceedings of the National Academy of Sciences of the United States of America.

In-vitro activity and β-lactamase stability of LY163892

H. Neu, N. Chin, C. Cao, 1988 .

SEPTICEMIA WITH NON-TYPHOID SALMONELLA

H. Neu, P. Imperato, C. Cherubin, 1974, Medicine.

The cyclic phosphodiesterases (3'-nucleotidases) of the enterobacteriaceae.

H. Neu, 1968, Biochemistry.

Release of Surface Enzymes in Enterobacteriaceae by Osmotic Shock

H. Neu, J. Chou, 1967, Journal of bacteriology.

Disk susceptibility of ofloxacin, a new carboxyquinolone

H. Neu, W. Mandell, 1985, Journal of Clinical Microbiology.

Oral ofloxacin therapy of infections due to multiply-resistant bacteria.

H. Neu, B. Scully, N. Clynes, 1991, Diagnostic microbiology and infectious disease.

Activity of 5-Episisomicin Compared with That of Other Aminoglycosides

H. Neu, K. Fu, 1978, Antimicrobial Agents and Chemotherapy.

InVitroStudyofNetilmicin Compared withOther Aminoglycosides

H. Neu, K. Fu, 1976 .

The 5'-nucleotidase of Escherichia coli. I. Purification and properties.

H. Neu, 1967, The Journal of biological chemistry.

Chemical evolution of the fluoroquinolone antimicrobial agents.

H. Neu, 1989, The American journal of medicine.

CLINICAL USE OF THE QUINOLONES

H. Neu, 1987, The Lancet.

Comparative antibacterial activity of a new oral cephalosporin, BMY-28100

H. Neu, N. Chin, 1987, Antimicrobial Agents and Chemotherapy.

New antibiotics: areas of appropriate use.

H. Neu, 1987, The Journal of infectious diseases.

Antibiotics in the second half of the 1980s. Areas of future development and the effect of new agents on aminoglycoside use.

H. Neu, 1986, The American journal of medicine.

Advances in cephalosporin therapy.

H. Neu, 1985, The American journal of medicine.

Clinical efficacy of ceftazidime. Treatment of serious infection due to multiresistant Pseudomonas and other gram-negative bacteria.

H. Neu, B. Scully, 1984, Archives of internal medicine.

Activity of cephalosporins against coagulase-negative staphylococci.

H. Neu, N. Chin, N. Neu, 1990, Diagnostic microbiology and infectious disease.

Antibacterial activity of amifloxacin (WIN 49, 375), a new quinolone agent.

H. Neu, P. Labthavikul, 1985, Diagnostic microbiology and infectious disease.

The in-vitro activity of EN 272, a quinolone-7-carboxylic acid, in comparison with other quinolones.

H. Neu, 1985, The Journal of antimicrobial chemotherapy.

In vitro activity and beta-lactamase stability of a monobactam, SQ 26,917, compared with those of aztreonam and other agents

H. Neu, P. Labthavikul, 1983, Antimicrobial Agents and Chemotherapy.

The in-vitro activity of O-demethylfortimicin.

H. Neu, 1983, The Journal of antimicrobial chemotherapy.

The use of azlocillin to treat serious infections.

A. Prince, H. Neu, C. Ortiz-Neu, 1983, The Journal of antimicrobial chemotherapy.

Synergy of fosmidomycin (FR-31564) and other antimicrobial agents

H. Neu, T. Kamimura, 1982, Antimicrobial Agents and Chemotherapy.

Use of piperacillin, a semisynthetic penicillin, in the therapy of acute exacerbations of pulmonary disease in patients with cystic fibrosis.

A. Prince, H. Neu, 1980, The Journal of pediatrics.

INTERACTION BETWEEN MOXALACTAM AND ALCOHOL

A. Prince, H. Neu, 1980, The Lancet.

Mezlocillin in the therapy of serious infections.

H. Neu, J. Jahre, S. Pancoast, 1979, The American journal of medicine.

Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969)

H. Neu, N. Chin, A. Novelli, 1988, Antimicrobial Agents and Chemotherapy.

In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa

H. Neu, N. Chin, A. Novelli, 1988, Antimicrobial Agents and Chemotherapy.

The Pharmacokinetics and Serum and Urine Bactericidal Activity of Ciprofloxacin

M. McElrath, H. Neu, B. Scully, 1985, Journal of clinical pharmacology.

Activities of New Beta-Lactam Antibiotics Against Isolates of Pseudomonas aeruginosa from Patients with Cystic Fibrosis

A. Prince, H. Neu, 1981, Antimicrobial Agents and Chemotherapy.

The 5′-Nucleotidases and Cyclic Phosphodiesterases (3′-Nucleotidases) of the Enterobacteriaceae

H. Neu, 1968, Journal of bacteriology.

A comparative study of ticarcillin plus tobramycin versus carbenicillin plus gentamicin for the treatment of serious infections due to gram-negative bacilli.

H. Neu, M. F. Parry, 1978, The American journal of medicine.

Inactivation of digoxin by Eubacterium lentum, an anaerobe of the human gut flora.

H. Neu, V. P. Butler, J. Lindenbaum, 1982, Transactions of the Association of American Physicians.

Direct detection and amplification of Helicobacter pylori ribosomal 16S gene segments from gastric endoscopic biopsies.

I. Weinstein, H. Neu, W. Jiang, 1990, Diagnostic microbiology and infectious disease.

Digoxin-inactivating bacteria: identification in human gut flora.

H. Neu, V P Butler, H C Neu, 1983, Science.

Blind therapy in emergencies.

H. Neu, 1975, Bulletin of the New York Academy of Medicine.

Acute interstitial nephritis due to amoxicillin therapy.

H. Neu, G. Appel, G. Garvey, 1981, Nephron.

Synergy of azlocillin with aminoglycosides.

H. Neu, N. Chin, 1983, The Journal of antimicrobial chemotherapy.

Shigella bacteremia in adults.

H. Neu, W. Mandell, 1986, JAMA.

Isolation of protoplasts in a case of enterococcal endocarditis.

H. Neu, B. Goldreyer, 1968, The American journal of medicine.

Antimicrobial agents: the old and the new.

H. Neu, 1989, American journal of infection control.

The role of Pseudomonas aeruginosa in infections.

H. Neu, 1983, The Journal of antimicrobial chemotherapy.

The pharmacokinetics of new cephalosporins: significance in clinical practice.

H. Neu, 1984, Bulletin of the New York Academy of Medicine.

Pharmacokinetics of ceftriaxone in patients with renal failure and in those undergoing hemodialysis

H. Neu, G. Appel, D. Cohen, 1983, Antimicrobial Agents and Chemotherapy.

Do we need the third-generation cephalosporins?

H. Neu, 1984, The Journal of antimicrobial chemotherapy.

A comparative study of the activity of cefamandole and other cephalosporins and analysis of the beta-lactamase stability and synergy of cefamandole with aminoglycosides.

H. Neu, K. Fu, 1978, The Journal of infectious diseases.

Pharmacokinetics of Cefamandole in the Presence of Renal Failure and in Patients Undergoing Hemodialysis

H. Neu, G. Appel, M. Goldberger, 1976, Antimicrobial Agents and Chemotherapy.

Beta-Lactamase Activity in Shigella sonnei

A. Prince, H. Neu, 1976, Antimicrobial Agents and Chemotherapy.

Antibiotic-associated pseudomembranous colitis in children.

A. Prince, H. Neu, H. C. Neu, 1979, Pediatric clinics of North America.

NEPHROTOXICITY OF ANTIMICROBIAL AGENTS — THE FIRST OF THREE PARTS

H. Neu, G. Appel, 1977, The New England journal of medicine.

Endocarditis: The problems remain and multiply

H. Neu, 2005, Infection.

Comparative pharmacokinetics of cefoperazone and cefamandole

H. Neu, E. Francke, S. Srinivasan, 1981, Antimicrobial Agents and Chemotherapy.

Clavulanic acid, a novel inhibitor of beta-lactamases.

H. Neu, K. Fu, 1978, Antimicrobial agents and chemotherapy.

New strategies for the 1990's: antibacterial therapy.

H. Neu, 1991, International journal of antimicrobial agents.

Tazobactam prevention of emergence of resistance.

H. Neu, N. Chin, W. Niu, 1989, Diagnostic microbiology and infectious disease.

Dosage recommendations for teicoplanin.

H. Neu, A. Wilson, R. Grüneberg, 1993, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of moxalactam in patients with renal failure and during hemodialysis

H. Neu, S. Srinivasan, 1981, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers

H. Neu, K. Fu, S. Srinivasan, 1981, Antimicrobial Agents and Chemotherapy.

The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, enterobacteriaceae and pseudomonas aeruginosa

H. Neu, N. Chin, P. Labthavikul, 1985, Infection.

A critical review of the dosage of teicoplanin in Europe and the USA.

H. Neu, A. Wilson, R. Grüneberg, 1994, International journal of antimicrobial agents.

Pharmacokinetics of sisomicin in normal patients and those with depressed renal function

H. Neu, G. Appel, M. Parry, 1976, Infection.

In Vitro Synergistic Effect of Netilmicin, a New Aminoglycoside Antibiotic

H. Neu, K. Fu, 1976, Antimicrobial Agents and Chemotherapy.

Antibacterial activity of DL 473, a C3-substituted rifamycin derivative

H. Neu, 1983, Antimicrobial Agents and Chemotherapy.

Intravenous/oral ciprofloxacin therapy of infections caused by multiresistant bacteria.

H. Neu, F. Briones, S. Davidson, 1989, The American journal of medicine.

Intravascular clotting and acute pancreatitis in primary hyperparathyroidism.

H. Neu, L. Baer, 1966, Annals of internal medicine.

The development of macrolides: clarithromycin in perspective.

H. Neu, 1991, The Journal of antimicrobial chemotherapy.

Successful treatment of Pseudomonas cepacia endocarditis in a heroin addict with trimethoprim-sulfamethoxazole.

H. Neu, G. Garvey, M. Beach, 1973, Journal of Infectious Diseases.

Fluid management in haemophilus influenzae meningitis

A. Prince, H. Neu, 2005, Infection.

The use of cefepime (BMY 28142) to treat respiratory infections.

H. Neu, B. Scully, N. Clynes, 1989, Diagnostic microbiology and infectious disease.

Synergistic activity of cefoperazone in combination with β-lactamase inhibitors

H. Neu, K. Fu, 1981 .

The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin.

H. Neu, N. Chin, P. Labthavikul, 1986, The Journal of antimicrobial chemotherapy.

In vitro activity and beta-lactamase stability of cefmenoxime

H. Neu, P. Labthavikul, 1982, Antimicrobial Agents and Chemotherapy.

Relation of β-Lactamase Activity and Cellular Location to Resistance of Enterobacter to Penicillins and Cephalosporins

H. Neu, E. Winshell, 1972, Antimicrobial Agents and Chemotherapy.

Relation of1-Lactamase Activity andCellular Location toResistance ofEnterobacter toPenicillins andCephalosporins

H. Neu, E. Winshell, 1972 .

Relation of 1-Lactamase Activity and Cellular Location to Resistance of Enterobacter to Penicillins and Cephalosporins

H. Neu, 2022 .

CYTOLOGICALLY PROVEN SERONEGATIVE LYME CHOROIDITIS AND VITRITIS

H. Neu, E. Greenebaum, H. Schubert, 1994, Retina.

The use of moxalactam in the treatment of serious infections due tu multi-resistant organisms

A. Prince, H. Neu, C. Ortiz-Neu, 1983, Infection.

CLINICAL USES OF CEPHALOSPORINS

H. Neu, 1982, The Lancet.

J774 macrophages secrete antibiotics via organic anion transporters.

H. Neu, T. Steinberg, S. Silverstein, 1992, The Journal of infectious diseases.

In vitro activity of chloramphenicol and thiamphenicol analogs

H. Neu, K. Fu, 1980, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Chloramphenicol and Thiamphenicol Analogs

H. Neu, 2022 .

The effect of exchange transfusion on the blood levels of ampicillin and gentamicin in neonates

A. Prince, H. Neu, D. Phaneuf, 2005, Infection.

Effect of Ethylenediaminetetraacetic Acid-Tris(hydroxymethyl)aminomethane on Release of the Acid-soluble Nucleotide Pool and on Breakdown of Ribosomal Ribonucleic Acid in Escherichia coli

H. Neu, T. D. Price, H. Neu, 1967, Journal of bacteriology.

Effect ofEthylenediaminetetraacetic Acid-Tris (hy- droxymethyl)aminomethane on Release ofthe Acid-soluble Nucleotide Poolandon Break- downofRibosomal Ribonucleic Acid inEscherichia coli

H. Neu, T. D. Price, D. Ashman, 1967 .

Effect of Ethylenediaminetetraacetic Acid-Tris(hy- droxymethyl)aminomethane

H. Neu, T. D. Price, D. Ashman, 2022 .

Relation of Lipopolysaccharide and Fatty Acid Ester Release to the Ethylenediaminetetraacetic Acid Alteration of Permeability in Enterobacteriaceae

H. Neu, E. Winshell, 1970, Journal of bacteriology.

Surface Localization of Escherichia coli 5′-Nucleotidase by Electron Microscopy

H. Neu, M. Tannenbaum, I. Nisonson, 1969, Journal of bacteriology.

Studies on the mechanism of hypersensitivity phenomena. IV. An isometric smooth muscle assay system.

A. G. Osler, H. Neu, H. Randall, 1961, Immunology.

Thrombocytosis: an acute-phase reactant, not an adverse reaction to the new beta-lactam antibiotics.

H. Neu, M. F. Parry, B. Scully, 1984, Diagnostic microbiology and infectious disease.

Infection problems for the 1990's--do we have an answer?

H. Neu, 1993, Scandinavian journal of infectious diseases. Supplementum.

Cephalosporin antibiotics: molecules that respond to different needs.

H. Neu, 1988, American journal of surgery.

Comparative studies of cefoxitin and cephalothin: an overview.

H. Neu, 1979, Reviews of infectious diseases.

Cephalosporins — Cefotaxime 10 years later, a major drug with continued use

H. Neu, 1991, Infection.

Antibacterial activity and beta-lactamase stability of temocillin

H. Neu, K. Jules, 1982, Antimicrobial Agents and Chemotherapy.

The comparative beta-lactamase resistance and inhibitory activity of 1-oxa cephalosporin, cefoxitin and cefotaxime.

H. Neu, K. Fu, 1979, The Journal of antibiotics.

Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism.

H. Neu, N. Chin, 1984, Diagnostic microbiology and infectious disease.

ALLERGIC CROSS-REACTIVITY OF TEICOPLANIN AND VANCOMYCIN

H. Neu, D. Goldberg, M. Mcelrath, 1986, The Lancet.

Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamases.

H. Neu, H. C. Neu, 1985, The American journal of medicine.

Laboratory assessment of antibacterial activity of zwitterionic 7-methoxyimino cephalosporins.

H. Neu, J. Pechère, W. Wilson, 1995, The Journal of antimicrobial chemotherapy.

Optimal characteristics of agents to treat uncomplicated urinary tract infections

H. Neu, 1992, Infection.

Definitions et classifications des β-lactamases

H. Neu, 1988 .

beta-Lactamase inhibitory activity of iodopenicillanate and bromopenicillanate

H. Neu, 1983, Antimicrobial Agents and Chemotherapy.

Inactivation of beta-lactam antibiotics by Legionella pneumophila

H. Neu, K. Fu, 1979, Antimicrobial Agents and Chemotherapy.

Meningitis, pneumonitis, and arthritis caused by Neisseria meningitidis group Y.

H. Neu, M. Katz, N. M. Yee, 1975, JAMA.

Changing patterns of hospital infections: implications for therapy. Changing mechanisms of bacterial resistance.

H. Neu, 1984, The American journal of medicine.

In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem

H. Neu, N. Chin, P. Labthavikul, 1986, Antimicrobial Agents and Chemotherapy.

Ciprofloxacin: an overview and prospective appraisal.

H. Neu, 1987, The American journal of medicine.

Relation of Cell Wall Lipid Content of Serratia marcescens to Resistance to Antimicrobial Agents

H. Neu, Elaine B. Winshell, 1974, Antimicrobial Agents and Chemotherapy.

Comparison of the Antibacterial Activity of Beta-Lactam Antibiotics and their Resistance to Hydrolysis by Beta-Lactamases

H. Neu, 1975 .

The release of the acid-soluble nucleotide pool of E. coli by EDTA-Tris☆

H. Neu, T. D. Price, D. Ashman, 1966 .

Effect of 3-Lactamase Location inEscherichia coli on Penicillin Synergy

H. Neu, 1969 .

Deaths from nosocomial infections: experience in a university hospital and a community hospital.

H. Neu, P. Gross, C. Van Antwerpen, 1980, The American journal of medicine.

In vitro activity of a new cephalosporin ME-1206 compared with other agents.

H. Neu, N. Chin, Y. Zhang, 1991, Diagnostic microbiology and infectious disease.

Comparative Inhibition of,B-Lactamases byNovelf8-Lactam Compounds

H. Neu, K. Fu, 1979 .

The pharmacokinetics of bacampicillin.

H. Neu, 1981, Reviews of infectious diseases.

Postsplenectomy infection.

H. Neu, E. Francke, 1981, The Surgical clinics of North America.

THE PHARMACOKINETICS OF NEW CEPHALOSPORINS: SIGNIFICANCE IN CLINICAL PRACTICE*

H. Neu, 2006 .

The nephrotoxicity of antimicrobial agents (third of three parts).

H. Neu, G. Appel, 1977, New England Journal of Medicine.

The activity of metal compounds against aerobic and anaerobic bacteria.

H. Neu, N. Chin, 1992, Diagnostic microbiology and infectious disease.

Pharmacological studies of 6 (D(-) -amino-p-hydroxyphenylacetamido) penicillanic acid in humans.

H. Neu, E. Winshell, 1970, Antimicrobial agents and chemotherapy.

Cost Effective Blood Cultures—Is It Possible or Impossible to Modify Behavior?

H. Neu, 1986, Infection Control.

In vitro studies of cephanone, a 3-heterocyclic-thiomethyl cephalosporin derivative.

H. Neu, E. Winshell, 1973, The Journal of antibiotics.

In vitro activity of LY146032 (Daptomycin), a new peptolide

H. Neu, F. Ehlert, 1987, European Journal of Clinical Microbiology.

Current state of infectious diseases--potential areas of directed therapy with aztreonam.

H. Neu, 1985, The American journal of medicine.

In vitro activity of cefquinome, a new cephalosporin, compared with other cephalosporin antibiotics.

H. Neu, J. Gu, N. Chin, 1992, Diagnostic microbiology and infectious disease.

Emerging trends in antimicrobial resistance in surgical infections. A review.

H. Neu, 1994, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

The role of amine buffers in EDTA toxicity and their effect on osmotic shock.

H. Neu, 1969, Journal of general microbiology.

Antibacterial Activity of Ceftizoxime, a ,B-Lactamase-Stable Cephalosporin

H. Neu, 2022 .

InVitro Activity ofS-Ofloxacin

H. Neu, 1989 .

Chloramphenicol and tetracyclines.

H. Neu, E. Francke, 1987, The Medical clinics of North America.

Overview of mechanisms of bacterial resistance.

H. Neu, 1989, Diagnostic microbiology and infectious disease.

Obstructive respiratory dysfunction in parkinsonian patients.

A. W. Brody, H. Neu, J. Connolly, 2015, The American review of respiratory disease.

Activity of cefsulodin and other agents against Pseudomonas aeruginosa.

H. Neu, B. Scully, 1984, Reviews of infectious diseases.

Otitis media: antibiotic resistance of causative pathogens and treatment alternatives

H. Neu, 1995 .

Gemfibrozil enhances the listeriacidal effects of fluoroquinolone antibiotics in J774 macrophages

H. Neu, S. Silverstein, D. Rudin, 1992, The Journal of experimental medicine.

Pharmacokinetics of Intravenous Cefotaxime in Patients Undergoing Chronic Hemodialysis

H. Neu, M. Saltzman, E. Francke, 1981, Therapeutic drug monitoring.

Comparison and Evaluation of Ticarcillin and Carbenicillin Using Disk Diffusion Methods

H. Neu, M. F. Parry, 1976, Antimicrobial Agents and Chemotherapy.

In vitro studies of a semisynthetic penicillin, 6-(D(-)- -carboxy-3-thienylacetamido) penicillanic acid (BRL 2288), active against Pseudomonas.

H. Neu, E. Winshell, 1970, Antimicrobial agents and chemotherapy.

In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins

H. Neu, P. Labthavikul, 1982, Antimicrobial Agents and Chemotherapy.

Rapid, reproducible enzyme immunoassay for tobramycin

H. Neu, P. Labthavikul, E. Francke, 1981, Journal of clinical microbiology.

Rapid, reproducible enzyme immunoassay for gentamicin

H. Neu, D. Phaneuf, E. Francke, 1980, Journal of clinical microbiology.

Oligonucleotide probe for detection and identification of Campylobacter pylori

H. Neu, S. Hoshina, M. Morotomi, 1989, Journal of clinical microbiology.

Resistance of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors.

H. Neu, N. Chin, G. Saha, 1989, Diagnostic microbiology and infectious disease.

Comparative in vitro activity and beta-lactamase stability of RU29246, the active metabolite of HR916B

H. Neu, N. Chin, K. Yu, 1992, European Journal of Clinical Microbiology and Infectious Diseases.

Comparative in vitro activity of a new quinolone, AM-1091

H. Neu, N. Chin, A. Novelli, 1989, Antimicrobial Agents and Chemotherapy.

The biochemical basis of antimicrobial and bacterial resistance.

H. Neu, 1987, Bulletin of the New York Academy of Medicine.

In vitro activity and beta-lactamase stability of GR69153, a new long-acting cephalosporin

H. Neu, J. Gu, N. Chin, 1991, Antimicrobial Agents and Chemotherapy.

In Vitro Activity and Beta-Lactamase Stability of BL-S786 Compared with Those of Other Cephalosporins

H. Neu, K. Fu, Prasit Aswapokee, 1978, Antimicrobial Agents and Chemotherapy.

Cefoxitin: an overview of clinical studies in the United States.

H. Neu, 1979, Reviews of infectious diseases.

Current practices in antimicrobial dosing.

H. Neu, H. C. Neu, 1981, Reviews of infectious diseases.

Antimicrobial activity and beta-lactamase stability of foramidocillin

H. Neu, W. Mandell, 1986, Antimicrobial Agents and Chemotherapy.

New oral and parenteral quinolones. A summary.

H. Neu, 1989, The American journal of medicine.

Mecillinam--an amidino penicillin which acts synergistically with other beta-lactam compounds.

H. Neu, 1977, The Journal of antimicrobial chemotherapy.

ORAL β-LACTAM ANTIBIOTICS FROM 1960 TO 1993

H. Neu, 1993 .

The epidemiology of hepatitis B infection in housestaff

H. Neu, M. F. Parry, L. Dobbs, 2005, Infection.

Editors' roundtable: Current formulas for P & T Committee success (Part 1).

H. Neu, A. Lipman, M. Weintraub, 1987, Hospital formulary.

In vitro activities of two oxazolidinone antimicrobial agents, DuP 721 and DuP 105

H. Neu, N. Chin, A. Novelli, 1988, Antimicrobial Agents and Chemotherapy.

Aspergillus Endocarditis in Childen: Case Report and Review of the Literature

A. Prince, H. Neu, R. Barst, 1981, Pediatrics.

Sisomicin therapy of serious gram-negative infections

H. Neu, G. Appel, M. Parry, 1976, Infection.

The pharmacology of orally administered ciprofloxacin.

M. McElrath, H. Neu, B. Scully, 1985, Drugs under experimental and clinical research.

The post-antimicrobial suppressive effect of quinolone agents.

H. Neu, N. Chin, W. Mandell, 1987, Drugs under experimental and clinical research.

In-vitro activity of two new quinolone antimicrobial agents, S-25930 and S-25932 compared with that of other agents.

H. Neu, N. Chin, 1987, The Journal of antimicrobial chemotherapy.

Risk factors for Candida species colonization of neonatal intensive care unit patients.

L. Saiman, R. Wenzel, H. Neu, 2001, The Pediatric infectious disease journal.

The 5'-nucleotidase of Escherichia coli. II. Surface localization and purification of the Escherichia coli 5'-nucleotidase inhibitor.

H. Neu, 1967, The Journal of biological chemistry.

Synergy of ciprofloxacin with fosfomycin in vitro against Pseudomonas isolates from patients with cystic fibrosis.

H. Neu, V. Figueredo, 1988, The Journal of antimicrobial chemotherapy.

FOSFOMYCIN TROMETAMOL : MANAGEMENT OF LOWER URINARY TRACT INFECTIONS

H. Neu, 1990 .

Issues in gram-positive infections: the present and the future.

H. Neu, 1988, The Journal of antimicrobial chemotherapy.

In vitro activity of Ro 23-9424, a dual-action cephalosporin, compared with activities of other antibiotics

H. Neu, J. Gu, 1990, Antimicrobial Agents and Chemotherapy.

Antibacterial therapy: problems and promises, Part I.

H. Neu, 1990, Hospital practice.

Prophylaxis--has it at last come of age?

H. Neu, 1979, The Journal of antimicrobial chemotherapy.

Toxoplasmosis transmitted at autopsy.

H. Neu, 1967, Journal of the American Medical Association (JAMA).

In-vitro activity of ceftazidime, a beta-lactamase stable cephalosporin.

H. Neu, 1981, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of amdinocillin and pivamdinocillin in normal volunteers.

H. Neu, J. Christenson, C. Ortiz-Neu, 1983, The American journal of medicine.

Fosfomycin trometamol versus amoxycillin--single-dose multicenter study of urinary tract infections.

H. Neu, 1990, Chemotherapy.

Treatment of pulmonary infections in patients with cystic fibrosis: a comparative study of ticarcillin and gentamicin.

H. Neu, C. Denning, M. F. Parry, 1977, The Journal of pediatrics.

Tobramycin and ticarcillin therapy for exacerbations of pulmonary disease in patients with cystic fibrosis.

H. Neu, M. F. Parry, 1976, The Journal of infectious diseases.

Resistance of Escherichia coli and Salmonella typhimurium to carbenicillin.

H. Neu, H. Swarz, 1969, Journal of general microbiology.

Lepromatous leprosy masquerading as disseminated tuberculosis.

H. Neu, J. Weissman, 1979, The American journal of medicine.

Adult Hemophilus influenzae meningitis; associated with disseminated intravascular coagulation.

H. Neu, J. Stein, R. Derossi, 1969, New York state journal of medicine.

Lack of Synergy of EDTA with Antimicrobials in Resistant Enterobacteriaceae

H. Neu, ELAINE B. WINSHELL, 1970, Nature.

In vitro antibacterial activity and beta-lactamase stability of E-0702, a new cephalosporin

H. Neu, P. Labthavikul, 1983, Antimicrobial Agents and Chemotherapy.

INFECTIONS CAUSED BY GRAM-NEGATIVE PATHOGENS: NEW CLINICAL CONSIDERATIONS*

H. Neu, 2006 .

Effect of ciprofloxacin on fecal flora of patients with cystic fibrosis and other patients treated with oral ciprofloxacin.

H. Neu, N. Chin, B. Scully, 1987, The American journal of medicine.

Management and prevention of infectious diseases

H. Neu, 1985 .

Quinolones. An overview.

H. Neu, 1990, Diagnostic microbiology and infectious disease.

Quinolones as Broad-spectrum Agents

H. Neu, 1990 .

The 5'-nucleotidases (uridine diphosphate sugar hydrolases) of the Enterobacteriaceae.

H. Neu, 1968, Biochemistry.

Clinical Pharmacology of the Antimicrobial Agents for Infections in the Ear, Nose and Throat

H. Neu, 1981, The Annals of otology, rhinology & laryngology. Supplement.

The safety and tolerance of mezlocillin.

H. Neu, M. F. Parry, 1982, The Journal of antimicrobial chemotherapy.